histopathology reporting guidelines for surgical cancer 3rd edition 2013
Histopathology Reporting: Guidelines for Surgical Cancer – 3rd Edition (2013)
$206.00 Original price was: $206.00.$4.99Current price is: $4.99. Add to cart
Sale!

Histopathology Reporting: Guidelines for Surgical Cancer – 3rd Edition (2013)

Original price was: $206.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Standardized Report: Histopathology Reporting: Guidelines for Surgical Cancer (3rd Edition)

In surgical oncology, the pathologist’s final report is the ultimate document; it dictates exactly what chemotherapy the patient receives, what radiation fields are targeted, and ultimately, the patient’s prognosis. If this report is missing a single critical data point (like the distance to the closest surgical margin or the exact number of positive lymph nodes), patient care is severely compromised. Histopathology Reporting: Guidelines for Surgical Cancer (3rd Edition) is the definitive, fiercely standardized manual designed to ensure absolute uniformity and completeness in cancer reporting. This volume provides the exact blueprints required to generate rigorous, internationally compliant synoptic reports.

Mastering Synoptic Reporting and Staging

The core philosophy of this text is structured, unambiguous data delivery. The authors aggressively detail the mandatory data elements required for every major solid tumor type. It dictates exactly how to apply the complex TNM staging system (Tumor, Node, Metastasis), ensuring that the pathologist provides the exact morphological and quantitative data the oncologist needs to assign the correct clinical stage.

Navigating Margins, Nodes, and Biomarkers

The book provides a masterclass in oncological data extraction. It dictates the exact, highly specific protocols for evaluating surgical margins (e.g., the difference between a “close” margin and an “involved” margin in breast cancer). It provides exhaustive guidelines on the mandatory inclusion of predictive biomarkers (like HER2, ER/PR, EGFR) in the final pathology report.

Frequently Asked Questions (FAQs)

Does this book teach you how to *diagnose* cancer?
No, it assumes you have already made the diagnosis. This book teaches you exactly *how to report* that diagnosis to the clinical team in a standardized, legally defensible, and clinically actionable format.

Who is the primary audience?
It is the absolute, mandatory bench-side manual for General Surgical Pathologists, Pathology Residents, and Laboratory Information System (LIS) Managers.